News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
125 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24443)
Month
January (2434)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2492)
September (2134)
Day
1 (180)
2 (176)
3 (167)
4 (36)
6 (28)
7 (20)
8 (209)
9 (212)
10 (153)
11 (45)
13 (31)
14 (133)
15 (141)
16 (97)
17 (129)
18 (39)
20 (21)
21 (93)
22 (125)
23 (99)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
Artificial intelligence
Deep Dive: How AI is now essential in biopharma
As Big Pharma adds AI technology to bolster drug development, a cadre of new, upstart biotechs are pushing drug discovery to new heights.
September 22, 2026
·
3 min read
·
Annalee Armstrong
GLP-1
Lilly presents early data supporting GLP-1/GIP candidate’s potential in depression, alcohol use disorder
With a trillion-dollar market cap and a wildly successful GLP-1 portfolio, Eli Lilly isn’t resting on its laurels. At the Psych Congress 2026, the company presented early-stage data that could support the potential of its next-gen GLP-1 and GIP receptor agonist to treat diseases far beyond obesity.
September 22, 2026
·
5 min read
·
Heather McKenzie
Press Releases
Ivonescimab First-Line Biliary Tract Cancer Phase III Overall Survival Data Selected as ESMO Late-Breaking Abstract; Nearly 30 Akeso Studies to Be Presented at ESMO 2026
September 22, 2026
·
6 min read
Press Releases
Bestzyme Launches World’s First Dedicated, Automated Smart Production Line for Sweet Proteins in Jinan
September 22, 2026
·
3 min read
Press Releases
BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset
September 22, 2026
·
2 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity
September 22, 2026
·
6 min read
Press Releases
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
September 22, 2026
·
6 min read
Press Releases
Genentech Announces Positive Phase II Results for Dual GLP-1/GIP Receptor Agonist Enicepatide in People Living With Type 2 Diabetes and Overweight or Obesity
September 22, 2026
·
5 min read
Press Releases
SynAct Pharma to Participate in Investor and Partnering Conferences
September 22, 2026
·
2 min read
Press Releases
Opterion Health Announces Positive Phase 1 Results for OPT101, Supporting Advancement to Phase 2a
September 22, 2026
·
4 min read
1 of 13
Next